by neuroviapeptides | Aug 8, 2026 | Research, Research Fundamentals
Are Peptides FDA Approved? The Research Reality A peptide’s molecular identity does not determine its FDA status. The intended use, finished dosage form, labeling, manufacturing controls, clinical evidence, and marketing claims determine the regulatory pathway. That...
by neuroviapeptides | Aug 8, 2026 | Cognitive & Neurological Research, Research, Research Fundamentals
NAD+: Research Priorities for Quality and Control NAD+ is often discussed as a longevity-related molecule, but the laboratory question is more exacting: what material is being measured, under what conditions, and how confidently can the result be reproduced? For...
by neuroviapeptides | Aug 7, 2026 | Research, Research Fundamentals
How to Qualify Peptide Vendors for Research A peptide that arrives with a stated purity but no batch-level evidence creates an avoidable variable in an analytical workflow. Knowing how to qualify peptide vendors means looking beyond a catalog claim and determining...
by neuroviapeptides | Aug 6, 2026 | Research
BAM15 in Mitochondrial Uncoupling Research Mitochondrial uncoupling experiments can become difficult to interpret long before data analysis begins. A small shift in cell density, substrate availability, solvent exposure, or assay timing may alter the apparent...
by neuroviapeptides | Aug 4, 2026 | Research
Best Peptide Analytical Workflows for Labs A peptide vial can arrive with a stated purity value, yet still create analytical uncertainty if its identity, salt form, moisture content, or handling history are not understood. The best peptide analytical workflows treat...
by neuroviapeptides | Aug 3, 2026 | Research
Essential Peptide Procurement Documents Checklist A peptide vial without its supporting record set is not a fully qualified research material. Essential peptide procurement documents establish whether a material can be identified, evaluated, received, stored, and used...
